Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Alagna

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Development and Disease|April 27, 2023
Dual Antiplatelet Therapy with Parenteral P2Y<sub>12</sub> Inhibitors: Rationale, Evidence, and Future DirectionsGiulia Alagna, Paolo Mazzone, Marco Contarini, et al.
The American Journal of Cardiology|March 9, 2026
A New Paradigm for Post-Infarction Ventricular Septal Defect: Stop Rescuing, Start StrategizingGiuseppe Andò, Giulia Alagna, Lucio Giuseppe Granata, et al.
Journal of Electrocardiology|January 18, 2026
Beyond STEMI criteria: The electrocardiographic "South African Flag Sign" revealing an isolated proximal ramus intermedius occlusionLucio Giuseppe Granata, Alfredo Busà, Marcello Marchetta, et al.
The American Journal of Cardiology|June 26, 2026
ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI HospitalizationGiuseppe Andò, Lucio Giuseppe Granata, Giulia Alagna, et al.
Heart (British Cardiac Society)|May 8, 2026
Stent thrombosis: an updated clinical overview from epidemiology to classification and managementLucio Giuseppe Granata, Marcello Marchetta, Giulia Alagna, et al.
International Journal of Cardiology|February 21, 2024
Monotherapy with P2Y<sub>12</sub>-inhibitors after dual antiplatelet therapy: Filling gaps in evidenceGiuseppe Andò, Luca Lombardo, Giulia Alagna, et al.
ESC Heart Failure|March 31, 2022
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicityDaniela Di Lisi, Cristina Madaudo, Giulia Alagna, et al.
Expert Review of Cardiovascular Therapy|March 19, 2026
Percutaneous coronary intervention in high bleeding risk patients: a review of contemporary management strategiesGiuseppe Andò, Giulia Cavolina, Alessio Villari, et al.
The American Journal of Cardiology|January 24, 2025
Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet Therapy in PCI Patients: A Systematic Review and Meta-AnalysisGiulia Alagna, Giancarlo Trimarchi, Alessia Cascone, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 25, 2026
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future DirectionsFrancesca Campanella, Francesco Barreca, Simona Giubilato, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Development and Disease|April 27, 2023
Dual Antiplatelet Therapy with Parenteral P2Y<sub>12</sub> Inhibitors: Rationale, Evidence, and Future DirectionsGiulia Alagna, Paolo Mazzone, Marco Contarini, et al.
The American Journal of Cardiology|March 9, 2026
A New Paradigm for Post-Infarction Ventricular Septal Defect: Stop Rescuing, Start StrategizingGiuseppe Andò, Giulia Alagna, Lucio Giuseppe Granata, et al.
Journal of Electrocardiology|January 18, 2026
Beyond STEMI criteria: The electrocardiographic "South African Flag Sign" revealing an isolated proximal ramus intermedius occlusionLucio Giuseppe Granata, Alfredo Busà, Marcello Marchetta, et al.
The American Journal of Cardiology|June 26, 2026
ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI HospitalizationGiuseppe Andò, Lucio Giuseppe Granata, Giulia Alagna, et al.
Heart (British Cardiac Society)|May 8, 2026
Stent thrombosis: an updated clinical overview from epidemiology to classification and managementLucio Giuseppe Granata, Marcello Marchetta, Giulia Alagna, et al.
International Journal of Cardiology|February 21, 2024
Monotherapy with P2Y<sub>12</sub>-inhibitors after dual antiplatelet therapy: Filling gaps in evidenceGiuseppe Andò, Luca Lombardo, Giulia Alagna, et al.
ESC Heart Failure|March 31, 2022
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicityDaniela Di Lisi, Cristina Madaudo, Giulia Alagna, et al.
Expert Review of Cardiovascular Therapy|March 19, 2026
Percutaneous coronary intervention in high bleeding risk patients: a review of contemporary management strategiesGiuseppe Andò, Giulia Cavolina, Alessio Villari, et al.
The American Journal of Cardiology|January 24, 2025
Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet Therapy in PCI Patients: A Systematic Review and Meta-AnalysisGiulia Alagna, Giancarlo Trimarchi, Alessia Cascone, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 25, 2026
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future DirectionsFrancesca Campanella, Francesco Barreca, Simona Giubilato, et al.
Pageof 2